News/Events
Subscribe to get latest news
News
Flamingo Therapeutics to Present at the BioEquity Europe and Knowledge for Growth Conferences in May 2022
Flamingo Therapeutics, a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that Mike Garrett, Chief Executive Officer, will present a company ...
Flamingo Therapeutics to Present at BioCapital Europe 2022
Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that Mike Garrett, Chief Executive Officer and Rob MacLeod, ...
Flamingo Therapeutics to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that Mike Garrett, Chief Executive Officer and Rob MacLeod, ...
Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology
Flamingo Therapeutics, Inc., a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that it has entered into an agreement ...